Vifor Pharma AG (VIFN:SW) (GNHAY) PT Lowered to CHF155 at Barclays

June 3, 2020 4:35 AM EDT
Get Alerts VIFN:SW Hot Sheet
Price: $0.00 --0%

Rating Summary:
    0 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 7 | Down: 15 | New: 24
Trade Now! 
Join SI Premium – FREE
Barclays lowered its price target on Vifor Pharma AG (VIFN:SW) (OTC: GNHAY) to CHF155.00 (from CHF170.00) while maintaining a Equalweight rating.

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst PT Change, Intl Ratings